3X3F
TRAIL-R2 Extracellular Region Complexed to a Fab fragment from Human Agonist Antibody KMTR2
Summary for 3X3F
| Entry DOI | 10.2210/pdb3x3f/pdb |
| Related | 3X3G |
| Descriptor | Heavy chain of KMTR2, Light chain of KMTR2, Tumor necrosis factor receptor superfamily member 10B, ... (7 entities in total) |
| Functional Keywords | trail-r2, agonist antibody, apoptosis-immune system complex, apoptosis/immune system |
| Biological source | Homo sapiens More |
| Total number of polymer chains | 3 |
| Total formula weight | 64943.57 |
| Authors | Tamada, T. (deposition date: 2015-01-20, release date: 2015-12-23, Last modification date: 2024-10-30) |
| Primary citation | Tamada, T.,Shinmi, D.,Ikeda, M.,Yonezawa, Y.,Kataoka, S.,Kuroki, R.,Mori, E.,Motoki, K. TRAIL-R2 Superoligomerization Induced by Human Monoclonal Agonistic Antibody KMTR2 Sci Rep, 5:17936-17936, 2015 Cited by PubMed Abstract: The fully human monoclonal antibody KMTR2 acts as a strong direct agonist for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor 2 (TRAIL-R2), which is capable of inducing apoptotic cell death without cross-linking. To investigate the mechanism of direct agonistic activity induced by KMTR2, the crystal structure of the extracellular region of TRAIL-R2 and a Fab fragment derived from KMTR2 (KMTR2-Fab) was determined to 2.1 Å resolution. Two KMTR2-Fabs assembled with the complementarity-determining region 2 of the light chain via two-fold crystallographic symmetry, suggesting that the KMTR2-Fab assembly tended to enhance TRAIL-R2 oligomerization. A single mutation at Asn53 to Arg located at the two-fold interface in the KMTR2 resulted in a loss of its apoptotic activity, although it retained its antigen-binding activity. These results indicate that the strong agonistic activity, such as apoptotic signaling and tumor regression, induced by KMTR2 is attributed to TRAIL-R2 superoligomerization induced by the interdimerization of KMTR2. PubMed: 26672965DOI: 10.1038/srep17936 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.1 Å) |
Structure validation
Download full validation report






